Eslicarbazepine Acetate
[(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate
Molecular Identity
Eslicarbazepine Acetate
[(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate
PubChem CID: 179344
Eslicarbazepine acetate is the acetate ester, with S configuration, of licarbazepine. An anticonvulsant, it is approved for use in Europe and the United States as an adjunctive therapy for epilepsy. It has a role as an anticonvulsant and a drug allergen. It is a carboxamide, an acetate ester, a dibenzoazepine and a member of ureas. It is functionally related to a licarbazepine.
2D Structure
Properties
C17H16N2O3
Molecular Formula
296.32
Molecular Weight
g/mol
296.1161
Exact Mass
Da
2
XLogP
Drug-like (Lipinski: < 5)
72.6
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
3
H-Bond Acceptors
440
Complexity
SMILES
Canonical SMILES
SMILES: CC(=O)OC1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)NIsomeric SMILES
SMILES: CC(=O)O[C@H]1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)NSynonyms(20)
Eslicarbazepine acetate236395-14-5BIA 2-093ZebinixAptiomExaliefStedesaErelibPazzulBIA-2-093SEP-0002093BEA68ZVB2KCHEBI:87016BIA-2093SEP0002093
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Eslicarbazepine Acetate
Loading drug network...